Search

everythinglearnresearchcommunity

for

Search:↓

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Wnt-signaling is regulated differently in skin cells and immune responses during wound healing.

CD44 variant changes start alopecia areata, but don't maintain it.

Retinol may affect immune responses in people with frequent skin boils.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

A new mouse model effectively mimics vitiligo for research and drug testing.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Autoimmune reactions may cause both alopecia areata and HAM.

Keratin 17 is important for skin's response to radiation, affecting many genes and cell division.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Targeting IL-17 could help treat pattern hair loss.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

MTX and GC combinations are the most effective for early rheumatoid arthritis.